i2b2 tranSMART Chairman of the Board
Congratulations to Zak on the recent publication of The AI REVOLUTION in MEDICINE: GPT-4 AND BEYOND and added title of Editor-In-Chief of a new journal from the New England Journal of Medicine entitled NEJM AI
Isaac Kohane, MD Ph D
Chair of the Department of Biomedical Informatics, Harvard Medical School
Marion V. Nelson Professor of Biomedical Informatics, Harvard Medical School
Associate Professor of Medicine, Brigham and Women’s Hospital
With generous support from
i2b2 Global South Network
This consortium consists of health-care institutions in limited-resource settings that are leveraging the i2b2 platform for facilitating the use of EHR data for clinical research, hospital operations and education. Currently the consortium includes sites from India and Nepal and is seeking to expand to other regions. This collaboration is to developed a resilient and cost-effective software stack suited for deployment in the low-resource setting.
Diane Keogh
Executive Director
Diane.Keogh@i2b2transmart.org
From The Executive Director’s Desk
Welcome to an Exciting 2025!
This year promises to be a transformative one as we continue our mission of advancing translational research through cutting-edge technology, global collaborations, and community-driven initiatives.
Strategic Updates from Our Board of Directors
Our Board of Directors remains a cornerstone of our success, guiding us with expertise from academic medical centers and industry leaders across the U.S. and Europe. Their strategic vision drives innovation and strengthens our foundation’s global impact.
➡ Meet our Board members Click HERE
Revolutionizing Healthcare with Dell Technologies
We are thrilled to extend our collaboration with Dell Technologies, which supports the groundbreaking Personalized Digital Medical Twin initiative.
Key Highlights:
- Explainable AI Integration: Harnessing transparent AI for more accurate patient representations, paving the way for precise cohort identification in clinical trials.
- Computed Phenotypes in Action: i2b2 v1.8.1 introduces algorithms that deliver deeper insights into patient conditions and empower clinical decision-making.
Save the Date: 2025 i2b2 tranSMART Symposium, June 9-10, 2025 | Boston, MA
Join thought leaders and innovators in translational research for two days of inspiration, learning, and collaboration.
Agenda Highlights:
- Keynote Speaker: Dr. Zak Kohane on “Human Values Project: The AI We Want for the Research We Need”.
- Spotlight on Innovations: Explore computed phenotypes and the transformative Digital Twin initiative.
- Real-World Use Cases: Learn how i2b2 tools are reshaping clinical research.
- Working Groups & Roadmaps: Discover community efforts and future directions in research informatics.
➡ Mark your calendar and join us for this can’t-miss event!
Introducing i2b2 v1.8.1: Innovation at Your Fingertips
We’re proud to announce the release of i2b2 v1.8.1, a leap forward in usability and functionality.
Top Features:
- Modern Interface: A sleek, intuitive design for an effortless user experience.
- OMOP Compatibility: Seamless integration for OHDSI community users.
- Loyalty Cohorts: Enhanced cohort development and management tools.
- Data Quality Insights: Tools to ensure the reliability of your data.
- Bulk Exporter: Simplified data export for analysis and reporting.
Coming Soon: Stay tuned for v1.8.2 and its exciting new features!
Expanding Horizons with the EnACT Network
The rollout of i2b2 v1.8.1 across the EnACT network marks a significant milestone, extending the reach of computational phenotypes and advancing translational research nationwide.
We Want to Hear from You!
Your input drives our success. Share your thoughts, join our initiatives, or simply reach out.
➡ Contact us: Click HERE
You must be logged in to post a comment.